on 28 Mar 2023
Last Applicant/ Owned by
LINYI CITY
SHANDONG PROVINCE
CN
276010
Serial Number
90831436 filed on 15th Jul 2021
Registration Number
7009081 registered on 28th Mar 2023
Correspondent Address
Paulo A. de Almeida
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Active chemical ingredients for use in the manufacture of pharmaceuticals and pharmaceutical substances for the treatment of anaphylactic reactions, pain, inflammation, cancer, oncological diseases, diabetes, obesity, cancer, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological disease Read More
Active chemical ingredients for use in the manufacture of pharmaceuticals and pharmaceutical substances for the treatment of anaphylactic reactions, pain, inflammation, cancer, oncological diseases, diabetes, obesity, cancer, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; active chemical ingredients for use in the manufacture of anti-inflammatory pharmaceutical preparations
No 90831436
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
01.07.02 -
Globes with meridians and parallel lines only
28.01.03 -
Japanese and Chinese characters Formerly Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters
Status Date | Action Taken |
---|---|
28th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
28th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
10th Jan 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
10th Jan 2023 | PUBLISHED FOR OPPOSITION |
21st Dec 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
07th Dec 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
07th Dec 2022 | EXAMINER'S AMENDMENT ENTERED |
07th Dec 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
07th Dec 2022 | EXAMINERS AMENDMENT E-MAILED |
07th Dec 2022 | EXAMINERS AMENDMENT -WRITTEN |